Title : Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus.

Pub. Date : 2021

PMID : 34489627






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 One of the therapeutic drugs for T2DM, dipeptidyl peptidase-4 (DPP-4) inhibitor, suppresses the degradation of incretins, glucagon-like peptides and glucose-dependent insulinotropic peptide. Glucose dipeptidyl peptidase 4 Homo sapiens
2 One of the therapeutic drugs for T2DM, dipeptidyl peptidase-4 (DPP-4) inhibitor, suppresses the degradation of incretins, glucagon-like peptides and glucose-dependent insulinotropic peptide. Glucose dipeptidyl peptidase 4 Homo sapiens